KR840008024A - 푸릴옥사졸일 아세트산 유도체의 제조방법 - Google Patents

푸릴옥사졸일 아세트산 유도체의 제조방법 Download PDF

Info

Publication number
KR840008024A
KR840008024A KR1019840000772A KR840000772A KR840008024A KR 840008024 A KR840008024 A KR 840008024A KR 1019840000772 A KR1019840000772 A KR 1019840000772A KR 840000772 A KR840000772 A KR 840000772A KR 840008024 A KR840008024 A KR 840008024A
Authority
KR
South Korea
Prior art keywords
compound
formula
furyloxazolyl
preparing
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019840000772A
Other languages
English (en)
Other versions
KR900002658B1 (ko
Inventor
카즈오 마쓰모또 (외 1)
Original Assignee
마쓰하라 이찌로
타나베 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마쓰하라 이찌로, 타나베 세이야꾸 가부시끼 가이샤 filed Critical 마쓰하라 이찌로
Publication of KR840008024A publication Critical patent/KR840008024A/ko
Application granted granted Critical
Publication of KR900002658B1 publication Critical patent/KR900002658B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

내용 없음.

Description

푸릴옥사졸일 아세트산 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 일반식(Ⅱ)화합물을 알킬화시켜 일반식(I-a) 화합물을 생성시키고, 필요에 따라서는 화합물(I-a)을 가수분해시켜 일반식 (I-b)화합물을 생성시키는 것을 특징으로 하는 일반식(I)화합물의 제조방법.
    상기식에서, R1및 R4는 각각 저급알킬이며, R2및 R3는 각각 수소원자 또는 저급알킬이며, 또한 고리 A는 페닐 또는 할로게노 페닐이다.
  2. 제1항에 있어서, 일반식(I-b) 화합물을 그의 약제학적으로 허용되는 염으로 전환시키는 방법.
  3. 제1항에 있어서, 화합물(I)이 에틸 2-[2-(4-클로로페닐)-5-(-3-푸릴)-4-옥사졸] 일프로피온네이트인 방법.
  4. 제1항에 있어서, 화합물(I)이 2-[2-(4-클로로페닐)-5-(-2-푸릴)-4-옥사졸일]-2-메틸프로피온산인 방법.
  5. 제1항에 있어서, 화합물(I)이 에틸 2-[2-(4-클로로페닐)-5-(-2-푸릴)-4-옥사졸일]프로피온네이트인 방법.
  6. 제1항에 있어서, 화합물(I)이 2-[2-(4-클로로페닐)-5-(-2-푸릴)-4-옥사졸일]프로피온산인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000772A 1983-02-18 1984-02-17 푸릴옥사졸일 아세트산 유도체의 제조방법 Expired KR900002658B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58-26814 1983-02-18
JP26814 1983-02-18
JP58026814A JPS59152382A (ja) 1983-02-18 1983-02-18 フリルオキサゾリル酢酸誘導体

Publications (2)

Publication Number Publication Date
KR840008024A true KR840008024A (ko) 1984-12-12
KR900002658B1 KR900002658B1 (ko) 1990-04-21

Family

ID=12203749

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000772A Expired KR900002658B1 (ko) 1983-02-18 1984-02-17 푸릴옥사졸일 아세트산 유도체의 제조방법

Country Status (5)

Country Link
EP (1) EP0120270B1 (ko)
JP (1) JPS59152382A (ko)
KR (1) KR900002658B1 (ko)
DE (1) DE3479888D1 (ko)
ES (1) ES8506702A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06212867A (ja) * 1992-11-30 1994-08-02 Toso Co Ltd コード操作可能なロールブラインド
CZ20032829A3 (cs) * 2001-04-16 2005-03-16 Tanabe Seiyaku Co., Ltd. Heterocyklické sloučeniny

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818186A (en) * 1956-07-20 1959-08-12 Shell Res Ltd Biologically active compositions containing dihydro-oxazolones
GB2080803B (en) * 1980-07-28 1984-01-18 Pfizer Hypoglycemic 5-substituted oxazolidine-2,4-diones
JPS58148882A (ja) * 1982-02-26 1983-09-05 Tanabe Seiyaku Co Ltd フリルオキサゾリル酢酸誘導体及びその製法

Also Published As

Publication number Publication date
JPS59152382A (ja) 1984-08-31
DE3479888D1 (en) 1989-11-02
ES529847A0 (es) 1985-08-01
ES8506702A1 (es) 1985-08-01
EP0120270A3 (en) 1987-04-01
EP0120270A2 (en) 1984-10-03
JPH0121148B2 (ko) 1989-04-19
KR900002658B1 (ko) 1990-04-21
EP0120270B1 (en) 1989-09-27

Similar Documents

Publication Publication Date Title
KR850002472A (ko) 5-피리딜-1,3-티아졸 유도체의 제조방법
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR870000322A (ko) 피리돈 카복실산 유도체의 제조방법
KR830006228A (ko) 이미다졸 유도체의 제조방법
KR870003991A (ko) 치환된 벤젠 유도체의 제조방법
KR890008150A (ko) 퀴놀린 카르본산 유도체
IE821394L (en) N-(4,5-dihydrothiazol-2-yl)-3-quinoline carboxamide¹derivatives
KR860007244A (ko) 퀴놀린 카복실산 유도체의 제조방법
KR860008210A (ko) 글리코펩타이드 유도체의 제조 방법
KR920016420A (ko) 치환된 테트라하이드로피리딘의 제조방법
KR880007494A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도
KR840001152A (ko) 신규 복소환(複素環) 화합물의 제법
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
KR890005076A (ko) 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제
KR850000455A (ko) 세팔로스포린 에스테르 유도체의 제조방법
KR850002268A (ko) 3-인돌카르복스아미드 유도체의 제조방법
KR840004121A (ko) 아즈렌 유도체의 안정화 방법
KR840003632A (ko) 푸릴옥사졸릴 아세트산 유도체의 제조방법
KR840001160A (ko) 벤조디옥산-이미다졸린 유도체의 제조방법
KR850000415A (ko) 퀴나졸리논 유도체의 제조방법
JPS5287164A (en) Thiazoline derivatives
KR870007149A (ko) 하이드록시아세트산 유도체의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR840009102A (ko) 치환된 이소퀴놀린 유도체의 제조방법
KR860002451A (ko) 아미드 화합물의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19930422

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19930422